Skip to main content

The Lymphoma Signalling lab is led by Dr Robbert Hoogeboom. Dr Hoogeboom’s work focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma. His team uses high content imaging of primary patient cells and novel in vivo mouse models to study the context in which malignant B cells see antigen and how antigen stimulation and BCR signalling influence the behaviour of the tumour cells and disease progression.

Our Partners

The Kay Kendall Leukaemia Fund logo

The Kay Kendall Leukaemia Fund

Leukaemia UK

Leukaemia UK